News and Insights

6.23.23

SCOTUS Slack Technologies Decision

Direct listings have some advantages over traditional, underwritten initial public offerings for companies seeking to become publicly traded, including allowing existing shareholders whose shares are…

6.06.24

Dykema Earns 16 Practice Area Rankings and 33 Individual Rankings in Chambers USA 2024

Dykema, a leading national law firm, announced today that it received 33 individual attorney rankings and 16 practice area rankings in the 2024 edition of Chambers USA: America’s Leading Lawyers for…

2.16.24

Dykema Completes Sale of Assets for TRxADE Health, Inc.

A Dykema team of Peter Waltz, Jon Meulemans, paralegal Jill Knutson, and, Kate Bechen, with the support of other colleagues, helped client TRxADE Health, Inc. (Nasdaq: MEDS) close on the sale of…

12.27.23

Dykema Advises PowerUp Acquisition Corp. in its Combination with Visiox Pharmaceuticals, Inc.

Dykema advised PowerUp Acquisition Corp in a business combination with Visiox Pharmaceuticals, Inc., a Commercial-Stage Biopharmaceutical Company to be Listed on Nasdaq.

11.09.23

Temperature Check: Aerospace M&A

Activity level: Warming up

5.16.24

Special Purchase Acquisitions Companies and Reverse Takeovers: Public Alternatives to Traditional IPOs

Kate Bechen and Peter Waltz will serve as featured presenters at the Association of Corporate Counsel Wisconsin 2024 Annual Conference and Meeting of Members on Thursday, May 16, 2024, at the Osthoff…

4.26.22

SPAC, IPO or Private Equity: Which Exit Fits, and Are You Ready?

Kate Bechen participated in the American Health Law Association’s Health Care Transactions 2022 program on April 26, 2022. Bechen’s session, “SPAC, IPO or Private Equity: Which Exit Fits, and Are You…